Site Map Site Map of http://www.researchandmarkets.com - Site Map - Pharmaceuticals and Healthcare    - Pharmaceuticals 1 (Latest Titles)    Pharmaceuticals 2    Pharmaceuticals 3    Pharmaceuticals 4       - Generics  << You are in This Category #  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   A ACE Inhibitor Intolerance: A major driver of growth for the Aiirbs static version printer friendly pdf version Actavis IMS Company Profile static version printer friendly pdf version An Exploration of Consolidation in the Generics Industry static version printer friendly pdf version Anti-hypertensives: Patent Defense Strategies - Combating Generic Competition Through Lifecycle Management static version printer friendly pdf version Asia-Pacific Generics static version printer friendly pdf version Authorized Generics: Look Before you Leap static version printer friendly pdf version Average Cost of Brand and Generic Drugs static version printer friendly pdf version ^ Top B Barr: PharmaVitae Generics Profile static version printer friendly pdf version Biogenerics: Challenges and Promise static version printer friendly pdf version Booming US Generic Drug Market static version printer friendly pdf version Business Strategies for Different Types of Biogenerics static version printer friendly pdf version ^ Top C CNS Generic Drugs: Prospects and Opportunities to 2012 static version printer friendly pdf version CNS Year in Review: 2001 static version printer friendly pdf version Combating Generics 2008: Counter-Generics Strategy, Tactics and Execution static version printer friendly pdf version Commercial Insight: Antibacterials - Regulations, Resistance & Generics static version printer friendly pdf version Commercial Insight: Migraine - Opportunities will Exist in the Wake of Generic Attack static version printer friendly pdf version Competitor Analysis: Biogenerics & Therapeutic Proteins static version printer friendly pdf version Current Cardiovascular and Diabetes Blockbusters - Brands at Risk Beware static version printer friendly pdf version ^ Top D Drug Delivery 2000: A Key Company and Market Analysis static version printer friendly pdf version Drugs of Tommorrow 2002: Pain static version printer friendly pdf version Drugs of Tomorrow 2001: Bacterial Infections static version printer friendly pdf version ^ Top E Emerging Generic Drug Companies Worldwide 2007 static version printer friendly pdf version Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs static version printer friendly pdf version European Generic Gastrointestinal Pharmaceutical Markets static version printer friendly pdf version European Generics static version printer friendly pdf version ^ Top F Follow-On Products as a Defense Against Generics static version printer friendly pdf version Front-End Strategies to Meet Generics Challenges and Reduce Pharmaceutical Risk static version printer friendly pdf version Future Growth Opportunities in Generics: The Impact of Consolidation on Market and Competitive Dynamics static version printer friendly pdf version ^ Top G Generic Drug Market in Canada static version printer friendly pdf version Generic Drug Share of Total Market, 1984-2020 static version printer friendly pdf version Generic Drugs: Technology, Trends, and Opportunities static version printer friendly pdf version Generic Handbook: A Guide to the Generic Drug Industry in the US, 2007 Edition static version printer friendly pdf version Generic Pharmaceuticals in Belgium: A Strategic Reference, 2006 static version printer friendly pdf version Generic Series: An Introduction To The Canadian Generics Market - Key Trends And Leading Companies Shaping The Market static version printer friendly pdf version Generics Defense Strategies: Effective Brand Protection through Patent, Formulation, OTC and DTC Strategies static version printer friendly pdf version Generics Erosion Patterns in the U.S. Market static version printer friendly pdf version Generics in Asia-Pacific static version printer friendly pdf version Generics in Belgium static version printer friendly pdf version Generics in Canada static version printer friendly pdf version Generics in China static version printer friendly pdf version Generics in Europe static version printer friendly pdf version Generics in France static version printer friendly pdf version Generics in Germany static version printer friendly pdf version Generics in Italy static version printer friendly pdf version Generics in Japan static version printer friendly pdf version Generics in Spain static version printer friendly pdf version Generics in the Animal Health Industry static version printer friendly pdf version Generics in the Netherlands static version printer friendly pdf version Generics in the United Kingdom static version printer friendly pdf version Generics in the United States static version printer friendly pdf version Generics Review 2000/ 2001 static version printer friendly pdf version Generics Substitution in the Spotlight static version printer friendly pdf version Generics will Play an Increasingly Important Role in the Pharma Industry static version printer friendly pdf version Generics: Global Industry Guide static version printer friendly pdf version Global Generics static version printer friendly pdf version Global Generics static version printer friendly pdf version Global Generics Guide 3rd Edition: Benchmarking Generics Company Capabilities and Strategy static version printer friendly pdf version Global Generics Guide: Benchmarking the Key Players static version printer friendly pdf version Global Generics Guide: Capitalizing On an $82 Billion Opportunity static version printer friendly pdf version Global Generics Guide: Part 2 - Benchmarking Country Markets and Strategic Issues static version printer friendly pdf version Global Generics Industry Report static version printer friendly pdf version Global Healthcare Review - October 2002 static version printer friendly pdf version Global Healthcare Review - September 2002 static version printer friendly pdf version Growth Strategies In Generics: Innovative And Aggressive Strategies And Their Impact On Branded Pharmaceuticals static version printer friendly pdf version ^ Top H Healthcare Review: Immune Disorders and Inflammation - September 2002 static version printer friendly pdf version Healthcare Review: Infectious Diseases - October 2002 static version printer friendly pdf version Healthcare Review: Licensing - October 2002 static version printer friendly pdf version Hepatitis C virus (HCV) - Fierce Competition for a Shrinking HCV Market?  static version printer friendly pdf version Hormonal Contraception: Market Update - Surviving the Generic Threat static version printer friendly pdf version Human Growth Hormone - Delivery Technology Driving Market Growth static version printer friendly pdf version ^ Top I Impact of Generics on the Antidepressant Market static version printer friendly pdf version Indian Generics, 2008-2012: The Growing Threat to Westernised Markets static version printer friendly pdf version Indian Global Generics Market Size, 2003-2010 static version printer friendly pdf version Injectable Generic Drugs: Prospects and Opportunities to 2010 static version printer friendly pdf version ^ Top M Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy static version printer friendly pdf version Market Dynamics 2001: Antidepressants - Absorbing the Impact of Generic Prozac static version printer friendly pdf version Market Dynamics 2001: Hormonals static version printer friendly pdf version Market Dynamics: HIV - Combating a Market Slowdown static version printer friendly pdf version Maximising the Drug Lifecycle static version printer friendly pdf version Mylan: PharmaVitae Generics Profile static version printer friendly pdf version ^ Top N New Dynamics and Challenges in the Generics Market 2007 static version printer friendly pdf version ^ Top O Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil static version printer friendly pdf version ^ Top P Pharaceutical Branding Strategies static version printer friendly pdf version Population Genetics and Microevolutionary Theory static version printer friendly pdf version Practical Defense Strategies for Combating Generics Competition static version printer friendly pdf version Pricing and Reimbursement Issues for Generics and Biosimilars static version printer friendly pdf version ^ Top R Reimbursement in Europe, Japan and the US: The Impact of Cost Shifting on Pharmaceutical Strategies static version printer friendly pdf version Retail Pharmacy Price Markups on Generic Drugs static version printer friendly pdf version ^ Top S Sandoz - PharmaVitae Generics Profile static version printer friendly pdf version SPECIAL REPORT: Patterns of Generic Erosion: An International Chartbook static version printer friendly pdf version Strategic Intelligence: The Top 12 Pharmaceutical Companies static version printer friendly pdf version Strategic Perspectives 2001: Portfolio Management in the Anti-Fungal Market static version printer friendly pdf version Strategic Perspectives: Allergic Rhinitis - Impact of a blockbuster going bust static version printer friendly pdf version Strategic Perspectives: Impact of the Cancer Generics Market static version printer friendly pdf version Strategies for Biogeneric Success static version printer friendly pdf version ^ Top T The Anemia Market: Biogenerics and Second-Generation Products Drive Change static version printer friendly pdf version The Biogenerics Market Outlook: An Analysis of Market Dynamics, Growth Drivers and Leading Players static version printer friendly pdf version The Blockbuster Drugs Outlook: Optimum management strategies throughout the product lifecycle static version printer friendly pdf version The European Generics Outlook: A Country-By-Country Analysis Of Developing Market Opportunities And Revenue Defense Strategies static version printer friendly pdf version The Generics Industry in 2005: A New Threat to Pharma static version printer friendly pdf version The Generics Outlook 2001 static version printer friendly pdf version The Latin American Market for Generic Drugs - A Comparative Study of 7 Key Markets static version printer friendly pdf version The Pharmaceuticals Industry Market Review static version printer friendly pdf version The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe static version printer friendly pdf version The World Generic Market Report 2008 static version printer friendly pdf version Therapeutic Proteins: Strategic Market Analysis and Forecasts to 2010 static version printer friendly pdf version Toward a Biogenerics Market: The Regulatory Conundrum static version printer friendly pdf version ^ Top U U.S. Drug Delivery Systems Market: Emerging Technologies, Strategic Alliances, Patent Disputes, Market Size and Forecasts and R&D Activities static version printer friendly pdf version U.S. Generic Pharmaceuticals Outlook static version printer friendly pdf version Update on Dermatology Market static version printer friendly pdf version US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts static version printer friendly pdf version ^ Top W World Generic Drug Markets: Competitive Benchmarking static version printer friendly pdf version World Generics and Biogenerics Markets static version printer friendly pdf version All rights reserved. © copyright 2006 Research and Markets Terms and conditions Privacy Policy